BackRELIEF THERAPEUTICS HOLDING ORD SHS Overview
RELIEF THERAPEUTICS HOLDING ORD SHS

RELIEF THERAPEUTICS HOLDING ORD SHS Discounted Cash Flow

Is RLFTF undervalued? Intrinsic value estimate stands at $-0.19.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-0.19

Current Fair Value

$-0.19
↓ 187.4% Downside

Overvalued by 187.4% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading

RELIEF THERAPEUTICS HOLDING ORD SHS (RLFTF) FAQ

The latest DCF fair value for RLFTF is $-0.19. Investors often review this figure alongside RELIEF THERAPEUTICS HOLDING ORD SHS's historical trend and sector peers before judging valuation or financial health.

A DCF fair value of $-0.19 for RELIEF THERAPEUTICS HOLDING ORD SHS suggests the stock may be overvalued by roughly 187.4% at today's price. That does not mean the market is 'wrong'; it means the model's cash-flow assumptions imply a different intrinsic value. Stress-test the estimate by comparing it with historical valuation ranges and peer multiples.

After noting RLFTF's DCF fair value ($-0.19), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.